AB020. Detailed dosimetry of mixed fields using boron neutron capture therapy for skin cancer treatments
Abstract

AB020. Detailed dosimetry of mixed fields using boron neutron capture therapy for skin cancer treatments

Jessica Sofía Riback1,2,3, Julia Sabrina Viglietti1,3,4, Agustina Mariana Portu1,3, Gustavo Santa Cruz1,2, Sara Josefina González1,2

1National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina; 2Computational Dosimetry and Treatment Planning Group, Boron Neutron Capture Therapy Department, Gerente de Área Aplicaciones Nucleares a la Salud (GAANS), National Atomic Energy Commission (CNEA), Buenos Aires, Argentina; 3National University of San Martín (UNSAM), Buenos Aires, Argentina; 4Radiobiology Department, National Atomic Energy Commission (CNEA), Buenos Aires, Argentina

Correspondence to: Jessica Sofía Riback, PhD student. National Scientific and Technical Research Council (CONICET), Buenos Aires, Argentina; Computational Dosimetry and Treatment Planning Group, Boron Neutron Capture Therapy Department, Gerente de Área Aplicaciones Nucleares a la Salud (GAANS), National Atomic Energy Commission (CNEA), Av. Gral. Paz 1499, B1650 Villa Maipú, Buenos Aires, Argentina; National University of San Martín (UNSAM), Buenos Aires, Argentina. Email: jessicariback@cnea.gob.ar; jessicariback@gmail.com.

Background: The present work is accomplished in the context of the Argentine Boron Neutron Capture Therapy project that involves a phase II clinical trial for the treatment of skin cancer, carried out by the National Atomic Energy Commission (CNEA) of Argentina in collaboration with medical institutions. Argentina has an open clinical protocol for the treatment of cutaneous melanoma of extremities. Irradiations are carried out at the RA-6 reactor. Over 100 lesions were treated following this protocol. An overall response was observed in 69.3% of the nodules, while 30.7% of the tumors remained stable. The main objective of this work is to improve dosimetry for the organ at risk, the skin, and to prevent potential early radiotoxic effects. The calculation of the absorbed dose calculation in the main organ at risk, i.e., the normal skin [as a result of the energy deposited by low linear energy transfer (LET) electrons, intermediate LET protons, and particles alpha and high LET 7Li nuclei], is usually performed on the basis of two approximations: (I) all the kinetic energy transferred to the charged particles is deposited locally [kinetic energy released in materials (KERMA) approximation]; and (II) the distribution of sources of charged particles produced by uncharged ones is spatially uniform in both tumor and normal tissue. For certain conditions these assumptions are not satisfied. Therefore, estimates of the dose by more detailed calculations are required.

Methods: The skin dosimetry is addressed following two approaches: the detailed computational simulation of the skin irradiation, and the experimental determination of the distribution of neutron-generated secondary particle sources in the tissue. In the first case, the approach is carried out by simulations of therapeutic irradiations and calculations of the detailed dosimetry, with the transport code PHITS. The construction and modelling of a more complex geometry than the one usually used in skin calculations is proposed, that involved a complete study of the anatomy and histology of human skin, considering different material compositions and processes that determine the heterogeneous accumulation of 10-B. In the second case, the neutron autoradiography technique is used to estimate the microdistribution and boron uptake in different skin structures and thus, to include this information to the developed computational model. Biological samples from a preclinical study on a large animal were used for this purpose.

Results: Preliminary results show that, on average, the dermis absorbs twice as much boron as the epidermis. Basal cells, a critical dermal population related to early effects on radiation, receive about 10 Gy more than the macroscopical skin model.

Conclusions: This study shows the importance of a more realistic skin model in the dosimetric analysis of skin treatments and explains the differences between dose calculation and effects observed on the tissue. More analysis is necessary.

Keywords: Computational dosimetry; skin cancer; neutron autoradiography


Acknowledgments

The authors acknowledge the members of the Neutron Autoradiography Laboratory for providing the technique that originated the autoradiographic images, and the RA-3 team for irradiating the samples at the thermal neutron column. They are also grateful to PHITS developers for providing the software that allow them simulate the therapeutic irradiation.


Footnote

Funding: This study was funded by CONICET.

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tro.amegroups.com/article/view/10.21037/tro-25-ab020/coif). R.J.S. reports funding from CONICET. The other authors have no conflicts of interest to declare.

Ethical Statement: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Experiments were performed on biological samples derived from a preclinical study on a large animal under a project license. The animal study protocol was approved by the Maimonides University Institutional Committee for the Use and Care of Experimental Animals (CICUAE, Resolution No. 39/11 - REPORT N 4/12).

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the noncommercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


doi: 10.21037/tro-25-ab020
Cite this abstract as: Riback JS, Viglietti JS, Portu AM, Cruz GS, González SJ. AB020. Detailed dosimetry of mixed fields using boron neutron capture therapy for skin cancer treatments. Ther Radiol Oncol 2025;9:AB020.

Download Citation